These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 32187017)

  • 1. Electrochemotherapy in treatment of canine oral malignant melanoma and factors influencing treatment outcome.
    Tellado MN; Maglietti FH; Michinski SD; Marshall GR; Signori E
    Radiol Oncol; 2020 Mar; 54(1):68-78. PubMed ID: 32187017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrochemotherapy in treatment of canine oral non-tonsillar squamous cell carcinoma. A case series report.
    Simčič P; Lowe R; Granziera V; Pierini A; Torrigiani F; Lubas G
    Vet Comp Oncol; 2020 Sep; 18(3):428-432. PubMed ID: 31419028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral Mucosa Model for Electrochemotherapy Treatment of Dog Mouth Cancer: Ex Vivo, In Silico, and In Vivo Experiments.
    Suzuki DOH; Berkenbrock JA; Frederico MJS; Silva FRMB; Rangel MMM
    Artif Organs; 2018 Mar; 42(3):297-304. PubMed ID: 29027689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A combination of electrochemotherapy, gene electrotransfer of plasmid encoding canine IL-12 and cytoreductive surgery in the treatment of canine oral malignant melanoma.
    Milevoj N; Tratar UL; Nemec A; Brožič A; Žnidar K; Serša G; Čemažar M; Tozon N
    Res Vet Sci; 2019 Feb; 122():40-49. PubMed ID: 30453179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retrospective analysis of 140 dogs with oral melanoma treated with external beam radiation.
    Proulx DR; Ruslander DM; Dodge RK; Hauck ML; Williams LE; Horn B; Price GS; Thrall DE
    Vet Radiol Ultrasound; 2003; 44(3):352-9. PubMed ID: 12816381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CSPG4-specific immunity and survival prolongation in dogs with oral malignant melanoma immunized with human CSPG4 DNA.
    Riccardo F; Iussich S; Maniscalco L; Lorda Mayayo S; La Rosa G; Arigoni M; De Maria R; Gattino F; Lanzardo S; Lardone E; Martano M; Morello E; Prestigio S; Fiore A; Quaglino E; Zabarino S; Ferrone S; Buracco P; Cavallo F
    Clin Cancer Res; 2014 Jul; 20(14):3753-62. PubMed ID: 24874834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of a xenogeneic DNA vaccine encoding for human tyrosinase as adjunctive treatment for oral malignant melanoma in dogs following surgical excision of the primary tumor.
    Grosenbaugh DA; Leard AT; Bergman PJ; Klein MK; Meleo K; Susaneck S; Hess PR; Jankowski MK; Jones PD; Leibman NF; Johnson MH; Kurzman ID; Wolchok JD
    Am J Vet Res; 2011 Dec; 72(12):1631-8. PubMed ID: 22126691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local control and distant metastasis after electrochemotherapy of a canine anal melanoma.
    Spugnini EP; Filipponi M; Romani L; Dotsinsky I; Mudrov N; Baroni A; Ruocco E; Laieta MT; Montesarchio V; Cassandro R; Citro G; Baldi A
    In Vivo; 2007; 21(5):897-9. PubMed ID: 18019432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrochemotherapy compared to surgery for treatment of canine mast cell tumours.
    Kodre V; Cemazar M; Pecar J; Sersa G; Cor A; Tozon N
    In Vivo; 2009; 23(1):55-62. PubMed ID: 19368125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulse-mediated chemotherapy enhances local control and survival in a spontaneous canine model of primary mucosal melanoma.
    Spugnini EP; Dragonetti E; Vincenzi B; Onori N; Citro G; Baldi A
    Melanoma Res; 2006 Feb; 16(1):23-7. PubMed ID: 16432452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retrospective analysis of the efficacy of Oncept vaccine for the adjunct treatment of canine oral malignant melanoma.
    Ottnod JM; Smedley RC; Walshaw R; Hauptman JG; Kiupel M; Obradovich JE
    Vet Comp Oncol; 2013 Sep; 11(3):219-29. PubMed ID: 23909996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrochemotherapy in the treatment of metastatic malignant melanoma: a prospective cohort study by InspECT.
    Kunte C; Letulé V; Gehl J; Dahlstroem K; Curatolo P; Rotunno R; Muir T; Occhini A; Bertino G; Powell B; Saxinger W; Lechner G; Liew SH; Pritchard-Jones R; Rutkowski P; Zdzienicki M; Mowatt D; Sykes AJ; Orlando A; Mitsala G; Rossi CR; Campana L; Brizio M; de Terlizzi F; Quaglino P; Odili J;
    Br J Dermatol; 2017 Jun; 176(6):1475-1485. PubMed ID: 28118487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of adjuvant carboplatin for treatment of dogs with oral malignant melanoma following surgical excision.
    Dank G; Rassnick KM; Sokolovsky Y; Garrett LD; Post GS; Kitchell BE; Sellon RK; Kleiter M; Northrup N; Segev G
    Vet Comp Oncol; 2014 Mar; 12(1):78-84. PubMed ID: 22737988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of Oncept melanoma vaccine in 69 canine oral malignant melanomas in the UK.
    Verganti S; Berlato D; Blackwood L; Amores-Fuster I; Polton GA; Elders R; Doyle R; Taylor A; Murphy S
    J Small Anim Pract; 2017 Jan; 58(1):10-16. PubMed ID: 28094857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome following curative-intent surgery for oral melanoma in dogs: 70 cases (1998-2011).
    Tuohy JL; Selmic LE; Worley DR; Ehrhart NP; Withrow SJ
    J Am Vet Med Assoc; 2014 Dec; 245(11):1266-73. PubMed ID: 25406707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Difference in outcome between curative intent vs marginal excision as a first treatment in dogs with oral malignant melanoma and the impact of adjuvant CSPG4-DNA electrovaccination: A retrospective study on 155 cases.
    Giacobino D; Camerino M; Riccardo F; Cavallo F; Tarone L; Martano M; Dentini A; Iussich S; Lardone E; Franci P; Valazza A; Manassero L; Del Magno S; De Maria R; Morello E; Buracco P
    Vet Comp Oncol; 2021 Dec; 19(4):651-660. PubMed ID: 33751759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of spontaneous canine mast cell tumors by electrochemotherapy combined with IL-12 gene electrotransfer: Comparison of intratumoral and peritumoral application of IL-12.
    Lampreht Tratar U; Milevoj N; Cemazar M; Znidar K; Ursic Valentinuzzi K; Brozic A; Tomsic K; Sersa G; Tozon N
    Int Immunopharmacol; 2023 Jul; 120():110274. PubMed ID: 37216797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intralesional implant for treatment of primary oral malignant melanoma in dogs.
    Kitchell BE; Brown DM; Luck EE; Woods LL; Orenberg EK; Bloch DA
    J Am Vet Med Assoc; 1994 Jan; 204(2):229-36. PubMed ID: 8144382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolongation of survival of dogs with oral malignant melanoma treated by en bloc surgical resection and adjuvant CSPG4-antigen electrovaccination.
    Piras LA; Riccardo F; Iussich S; Maniscalco L; Gattino F; Martano M; Morello E; Lorda Mayayo S; Rolih V; Garavaglia F; De Maria R; Lardone E; Collivignarelli F; Mignacca D; Giacobino D; Ferrone S; Cavallo F; Buracco P
    Vet Comp Oncol; 2017 Sep; 15(3):996-1013. PubMed ID: 27146852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant melanoma in 63 dogs (2001-2011): the effect of carboplatin chemotherapy on survival.
    Brockley LK; Cooper MA; Bennett PF
    N Z Vet J; 2013 Jan; 61(1):25-31. PubMed ID: 22913610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.